Concepts (47)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 3 | 2022 | 67 | 1.040 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2021 | 9 | 0.750 |
Why?
|
| Pancreas | 2 | 2020 | 28 | 0.740 |
Why?
|
| Intestine, Small | 1 | 2021 | 28 | 0.730 |
Why?
|
| Lipase | 1 | 2020 | 5 | 0.710 |
Why?
|
| Betacoronavirus | 1 | 2020 | 72 | 0.650 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 210 | 0.650 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 84 | 0.620 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 87 | 0.620 |
Why?
|
| Pandemics | 1 | 2020 | 238 | 0.610 |
Why?
|
| Obesity | 1 | 2020 | 279 | 0.580 |
Why?
|
| United States | 2 | 2021 | 1989 | 0.240 |
Why?
|
| Risk Factors | 2 | 2021 | 2265 | 0.230 |
Why?
|
| Receptors, Opioid, mu | 1 | 2022 | 3 | 0.200 |
Why?
|
| Morphine | 1 | 2022 | 62 | 0.190 |
Why?
|
| Symptom Assessment | 1 | 2020 | 22 | 0.180 |
Why?
|
| Feasibility Studies | 1 | 2021 | 210 | 0.180 |
Why?
|
| Opioid-Related Disorders | 1 | 2021 | 47 | 0.170 |
Why?
|
| Databases, Factual | 1 | 2021 | 333 | 0.160 |
Why?
|
| Sex Factors | 1 | 2020 | 450 | 0.160 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 17 | 0.160 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 32 | 0.150 |
Why?
|
| Incidence | 1 | 2021 | 716 | 0.150 |
Why?
|
| Epithelial Cells | 1 | 2018 | 76 | 0.150 |
Why?
|
| Body Mass Index | 1 | 2020 | 427 | 0.150 |
Why?
|
| Macrophages | 1 | 2018 | 105 | 0.150 |
Why?
|
| Humans | 5 | 2022 | 26257 | 0.140 |
Why?
|
| Mutation | 1 | 2018 | 314 | 0.140 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 936 | 0.130 |
Why?
|
| Prospective Studies | 1 | 2021 | 1668 | 0.130 |
Why?
|
| Female | 3 | 2021 | 14516 | 0.130 |
Why?
|
| Cohort Studies | 1 | 2020 | 1838 | 0.120 |
Why?
|
| Male | 2 | 2021 | 14123 | 0.120 |
Why?
|
| Adult | 1 | 2021 | 7447 | 0.080 |
Why?
|
| Middle Aged | 1 | 2020 | 8599 | 0.070 |
Why?
|
| Aged | 1 | 2020 | 8763 | 0.070 |
Why?
|
| Mice | 2 | 2022 | 1277 | 0.070 |
Why?
|
| Animals | 2 | 2022 | 3386 | 0.050 |
Why?
|
| Cell Line | 1 | 2022 | 244 | 0.050 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 4 | 0.040 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 10 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 26 | 0.040 |
Why?
|
| Precancerous Conditions | 1 | 2018 | 21 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2018 | 39 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2018 | 22 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2018 | 162 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 231 | 0.040 |
Why?
|